National PBM Monograph Template

Area under the curve (AUC) increases proportionally with doses up to 60 mg Percent coefficient of intersubject variation ranges between 30 and 60% in terms of peak and average exposure to tolvaptan Moderate or severe hepatic impairment or congestive heart failure decrease the clearance and increase the volume of distribution of tolvaptan but ... ................
................